Published in J Neurochem on December 01, 1993
Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet (1997) 3.12
5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol Sci (1993) 2.65
Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry (1994) 2.54
Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. J Neurosci (2001) 1.92
Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos. Biol Psychiatry (1999) 1.40
Serotonergic status in human blood. Life Sci (1988) 1.38
Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci (2001) 1.29
Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology (1997) 1.15
Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn Schmiedebergs Arch Pharmacol (1991) 1.15
Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol (1992) 1.12
Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol (1996) 1.11
Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects. Mol Psychiatry (2011) 1.11
Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology (1996) 1.01
Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors. J Neurochem (1997) 1.01
How long should pindolol be associated with paroxetine to improve the antidepressant response? J Clin Psychopharmacol (1997) 1.00
The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. J Neurochem (2001) 0.97
The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Br J Pharmacol (1997) 0.94
Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors. Neuropsychopharmacology (2002) 0.93
Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse (1993) 0.92
Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology (2001) 0.92
Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. J Clin Psychopharmacol (2001) 0.92
In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain. Psychopharmacology (Berl) (2007) 0.91
Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport (1999) 0.90
The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci Lett (1996) 0.90
Dual control of dorsal raphe serotonergic neurons by GABA(B) receptors. Electrophysiological and microdialysis studies. Synapse (2000) 0.90
Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-). Genes Brain Behav (2006) 0.90
Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors. Br J Pharmacol (2010) 0.88
A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat. Br J Pharmacol (1998) 0.88
Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Hum Exp Toxicol (1996) 0.87
Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur J Pharmacol (1998) 0.87
In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J Neurochem (1993) 0.86
Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. Br J Pharmacol (2000) 0.86
Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats. J Neurochem (1996) 0.86
Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. Br J Pharmacol (2012) 0.84
Seasonal changes of plasma serotonin and related parameters: correlation with environmental measures. Biol Psychiatry (1989) 0.84
Decreased plasma serotonin in melancholic patients: a study with clomipramine. Biol Psychiatry (1987) 0.84
Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain. Eur J Neurosci (1997) 0.82
Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors. Eur J Pharmacol (1994) 0.82
Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. J Neurosci (1994) 0.82
Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments. J Clin Psychopharmacol (1998) 0.82
Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans. J Neurochem (1990) 0.82
Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol (2001) 0.81
Regional distribution of extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain of freely moving rats. J Neurochem (1991) 0.81
Serotonin in body fluids: characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC method. Life Sci (1985) 0.81
The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rats. J Neural Transm Suppl (1994) 0.81
Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue. Life Sci (1994) 0.81
RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Transl Psychiatry (2013) 0.81
GABAB-RI receptors in serotonergic neurons: effects of baclofen on 5-HT output in rat brain. Neuroreport (2000) 0.81
Two actions are better than one: avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors. Int Clin Psychopharmacol (1996) 0.80
Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus. J Neurochem (2001) 0.80
Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine. Br J Pharmacol (1992) 0.80
Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood. J Neurochem (1992) 0.80
In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.80
Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain. Eur J Pharmacol (1994) 0.80
Basal and stimulated extracellular serotonin concentration in the brain of rats with altered serotonin uptake. Synapse (1998) 0.80
Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. Eur J Neurosci (2001) 0.80
A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. Arch Gen Psychiatry (1999) 0.80
Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. J Neurochem (1996) 0.80
New antidepressant strategy based on acute siRNA silencing of 5-HT1A autoreceptors. Mol Psychiatry (2012) 0.79
Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. J Affect Disord (1992) 0.79
In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.79
Regional distribution of lindane in rat brain. Toxicology (1988) 0.79
In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.78
Effects of the antidepressant drug tianeptine on plasma and platelet serotonin concentrations in the rat. Eur J Pharmacol (1991) 0.78
Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents. Eur J Neurosci (1999) 0.78
Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J Neurochem (1993) 0.78
In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies. J Pharmacol Exp Ther (1996) 0.78
[Serotonergic control of prefrontal cortex]. Rev Neurol (2004) 0.78
p-chlorophenylalanine increases tryptophan-5-hydroxylase mRNA levels in the rat dorsal raphe: a time course study using in situ hybridization. J Neurochem (1993) 0.77
A new mass fragmentographic method for the simultaneous analysis of tryptophan, tryptamine, indole-3-acetic acid, serotonin, and 5-hydroxyindole-3-acetic acid in the same sample of rat brain. Anal Biochem (1979) 0.77
Plasma free 5HT, plasma 5HIAA and whole blood 5HT in the rat. Adv Exp Med Biol (1991) 0.77
Liquid-chromatographic determination of indole-3-acetic acid and 5-hydroxyindole-3-acetic acid in human plasma. Clin Chem (1983) 0.77
Comparison of high-performance liquid chromatography and gas chromatography-mass spectrometry for the analysis of indole-3-acetic acid in brain tissue. J Chromatogr (1984) 0.77
Imidazoline-induced inhibition of firing rate of 5-HT neurons in rat dorsal raphe by modulation of extracellular 5-HT levels. Ann N Y Acad Sci (1999) 0.77
Plasma free 5HT and platelet 5HT in depression: case-control studies and the effect of antidepressant therapy. Adv Exp Med Biol (1991) 0.77
Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.77
Pindolol, 5-hydroxytryptamine, and antidepressant augmentation. Arch Gen Psychiatry (1995) 0.76
Changes in polyamine levels in rat brain after systemic kainic acid administration: relationship to convulsant activity and brain damage. J Neurochem (1991) 0.76
Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls. J Affect Disord (1993) 0.76
Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain. Synapse (1999) 0.76
Local modulation of the 5-HT release in the dorsal striatum of the rat: an in vivo microdialysis study. Eur Neuropsychopharmacol (2000) 0.76
Differential response of rat brain polyamines to convulsant agents. Life Sci (1991) 0.76
Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats. Neuropsychopharmacology (1999) 0.76
Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. J Neural Transm Suppl (1990) 0.76
Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus. Eur J Pharmacol (1994) 0.76
Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. J Clin Psychopharmacol (1992) 0.75
Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism. Neurosci Lett (1995) 0.75
Adsorption of tryptophan metabolites from physiological fluids on XAD-2 and determination by single ion monitoring. Biomed Mass Spectrom (1976) 0.75
Determination of tryptamine in brain tissue by capillary gas chromatography mass spectrometry (selected ion monitoring). Biomed Mass Spectrom (1984) 0.75
On the metabolic origin of plasmatic indole-3-acetic acid in the rat. Biochem Pharmacol (1983) 0.75
3-Hydroxybutyrate co-infused with noradrenaline decreases resulting plasma levels of noradrenaline in Wistar rats. J Exp Biol (1997) 0.75
Free 5-hydroxytryptamine in plasma: fact or artifact? Clin Chem (1986) 0.75
Comparative ontogenesis of brain tryptamine, serotonin, and tryptophan. J Neurochem (1985) 0.75
Effects of clomipramine on extracellular serotonin in the rat frontal cortex. Adv Exp Med Biol (1991) 0.75
Quantitation of total MHPG in the rat brain using a non enzymatic hydrolysis procedure. Effects of drugs. Life Sci (1986) 0.75
Evaluation of the potential of thermospray liquid chromatography-mass spectrometry in neurochemistry. J Chromatogr (1987) 0.75
The effect of non-convulsant doses of lindane on temperature and body weight. Toxicology (1988) 0.75
Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain? Eur J Pharmacol (1998) 0.75